GenScript is the world leader in biotechnology reagent services, providing life sciences services and products to over 200,000 scientists in over 100 countries worldwide. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and establish fully-integrated capabilities for custom peptide synthesis, protein expression, protein engineering, custom antibody development and engineering, synthetic biology, in vitro/in vivo pharmacology as well as a variety of different catalogue products.

After almost two decades of rapid growth, the company has expanded its business in recent years to the fields of immunotherapy, CDMO, laboratory equipment and microbiology, to further fulfil its core mission of making people and nature healthier through biotechnology.

With global support from its customers and 2600+ employees across the globe, GenScript continues to strive towards their vision of being the most reliable biotech company in the world, in service of a better and healthier future.